Table 11

 Treatment of hypertension and occurrence of heart failure: meta-analysesw65 w66

RR for developing heart failure (95% CI)
ACE, angiotensin converting enzyme; CI, confidence interval; RR, relative risk.
β-blocker vs placebo0.58 (0.40 to 0.84)
Diuretic (low dose) vs placebo0.58 (0.44 to 0.76)
Diuretic (high dose) vs placebo0.17 (0.07 to 0.41)
ACE inhibitor vs placebo0.84 (0.68 to 1.04)
Calcium channel blocker vs placebo0.72 (0.48 to1.07)